Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Financial Statements

300 Followers

Neuphoria Therapeutics Financial Overview

Neuphoria Therapeutics's market cap is currently $20.08M. The company's EPS TTM is $; its P/E ratio is -0.51; Neuphoria Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Income Statement
Total Revenue	$ 1.17M	$ 15.65M	$ 0.00	AU$ 0.00	AU$ 383.16K
Gross Profit	$ 511.21K	$ 14.99M	$ -662.99K	AU$ -671.48K	AU$ -9.98M
Operating Income	$ -9.81M	$ -1.13M	$ -26.79M	AU$ -33.09M	AU$ -31.02M
EBITDA	$ -9.15M	$ -121.90K	$ -25.65M	AU$ -31.45M	AU$ -30.25M
Net Income	$ -13.45B	$ -369.63K	$ -15.49M	AU$ -32.18M	AU$ -22.94M
Balance Sheet
Cash & Short-Term Investments	$ 19.87B	$ 21.59M	$ 12.61M	AU$ 8.06M	AU$ 33.56M
Total Assets	$ 28.71B	$ 43.44M	$ 27.65M	AU$ 19.39M	AU$ 65.30M
Total Debt	$ 34.34K	$ 226.49K	$ 272.74K	AU$ 582.35K	AU$ 693.55K
Net Debt	$ -19.87B	$ -21.37M	$ -12.34M	AU$ -7.80M	AU$ -32.87M
Total Liabilities	$ 4.11B	$ 14.57M	$ 10.16M	AU$ 4.74M	AU$ 8.40M
Stockholders' Equity	$ 24.60B	$ 28.87M	$ 17.49M	AU$ 14.65M	AU$ 56.91M
Cash Flow
Free Cash Flow	$ -12.35B	$ 77.23M	$ -14.68M	AU$ -9.85M	AU$ -21.75M
Operating Cash Flow	$ -12.35B	$ 77.23M	$ -14.68M	AU$ -9.85M	AU$ -21.75M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	AU$ 0.00	AU$ 621.64K
Financing Cash Flow	$ 17.92B	$ 1.53B	$ 15.11M	AU$ 5.81M	AU$ 26.99M

Neuphoria Therapeutics Earnings and Revenue History

Income Statement >

Neuphoria Therapeutics Debt to Assets

Balance Sheet >

Neuphoria Therapeutics Cash Flow

Cash Flow >

Neuphoria Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >